Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Sigyn Therapy
Therapeutic Opportunities
Overview
Sepsis
Community Acquired Pneumonia
Emerging Pandemic Threats
ESRD Inflammation and Endotoxemia
News
Press Releases
Presentations
Resources
Media
Investors
Overview
News & Events
Company Info
Email Alerts
Financial Info
Stock Data
SEC Filings
Governance
Contact
CEO Notes
News & Events
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
Email Alerts
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Recent News
View All News
Mar 31, 2023 9:45am EDT
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K
Nov 15, 2022 7:30am EST
Sigyn Therapeutics Announces Third Quarter 2022 Financial Results
View All News
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Sign Up
Email Alerts
Contacts
RSS News Feed
